Sunday, July 14, 2024 8:47:59 PM
Fine, it's my opinion that many of the longs here believe much the same thing, LP has a share price in mind as the least she'd consider in a buyout. I've never heard it directly from her, but I do believe that some of the biggest investors who also hold many warrants or options for additional shares who've actually helped finance the company at times, IMHO, have heard such things.
I'm sure many here have million share portfolios, I really can't say how many shares people I've suggested NWBO to have, but including my holdings it may exceed a million shares, I'm certain it's over half a million. Even at todays share price I'm sure there are many people with over a million dollars worth of NWBO today. I won't be there till it's nearer $2.50. That's fine with me, I expect it this year, who knows it could happen later this month, or in the next couple months. I could be wrong, but I certainly believe an approval should be worth that much.
As for right, or wrong about investments, it took decades, but ultimately I was right about IMGN. I feel much the same about NWBO. I don't believe it will take multiple additional decades, as IMGN did, but things in the biotech world always seem to take longer than investors think, and often longer than the CEO's believe as well. I believe we're very close, but that could be tomorrow, next week, month, or quarter. I have had small investments in biotech's that completely failed, but the larger investments were IMGN, NWBO, and recently with gains from the buyout of IMGN some AVXL and ARDX.
Gary
I'm sure many here have million share portfolios, I really can't say how many shares people I've suggested NWBO to have, but including my holdings it may exceed a million shares, I'm certain it's over half a million. Even at todays share price I'm sure there are many people with over a million dollars worth of NWBO today. I won't be there till it's nearer $2.50. That's fine with me, I expect it this year, who knows it could happen later this month, or in the next couple months. I could be wrong, but I certainly believe an approval should be worth that much.
As for right, or wrong about investments, it took decades, but ultimately I was right about IMGN. I feel much the same about NWBO. I don't believe it will take multiple additional decades, as IMGN did, but things in the biotech world always seem to take longer than investors think, and often longer than the CEO's believe as well. I believe we're very close, but that could be tomorrow, next week, month, or quarter. I have had small investments in biotech's that completely failed, but the larger investments were IMGN, NWBO, and recently with gains from the buyout of IMGN some AVXL and ARDX.
Gary
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
